TY - JOUR
T1 - Erythrocyte membrane protein changes in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease
T2 - an example of postsynthetic modification of membrane proteins.
AU - Allen, D. W.
AU - Flynn, T. P.
AU - Johnson, G. J.
PY - 1982
Y1 - 1982
N2 - 1. G6PD mutants with CHD have decreased GSH, despite reticulocytosis, and increased membrane polypeptide aggregates. Aggregates increase logarithmically with decrease in RBC GSH. 2. These aggregates contain spectrin and can be depolymerized by disulfide reducing agents. Disulfide bonds between spectrin molecules and between the cytoskeleton and the cytoplasmic protein rigidify the red cell membrane and decrease RBC survival. 3. Direct oxidative damage of the RBC membrane, not Heinz body formation, explains the hemolytic anemia of G6PD mutants with CHD. This membrane damage may constitute a useful model system of oxidant-induced injury of other cells, and is an example of postsynthetic modification of membrane proteins by a nonmembrane gene.
AB - 1. G6PD mutants with CHD have decreased GSH, despite reticulocytosis, and increased membrane polypeptide aggregates. Aggregates increase logarithmically with decrease in RBC GSH. 2. These aggregates contain spectrin and can be depolymerized by disulfide reducing agents. Disulfide bonds between spectrin molecules and between the cytoskeleton and the cytoplasmic protein rigidify the red cell membrane and decrease RBC survival. 3. Direct oxidative damage of the RBC membrane, not Heinz body formation, explains the hemolytic anemia of G6PD mutants with CHD. This membrane damage may constitute a useful model system of oxidant-induced injury of other cells, and is an example of postsynthetic modification of membrane proteins by a nonmembrane gene.
UR - http://www.scopus.com/inward/record.url?scp=0020392727&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020392727&partnerID=8YFLogxK
M3 - Article
C2 - 7156168
AN - SCOPUS:0020392727
SN - 0361-7742
VL - 97
SP - 33
EP - 43
JO - Progress in clinical and biological research
JF - Progress in clinical and biological research
ER -